Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab
Blood Adv
.
2019 Apr 9;3(7):980-983.
doi: 10.1182/bloodadvances.2018030411.
Authors
Catherine Lai
1
,
Vishal Ranpura
1
,
Colin Wu
1
,
Matthew J Olnes
1
,
Ankur R Parikh
1
,
Aarthi Shenoy
1
,
Julie Thompson
1
,
Barbara Weinstein
1
,
Phillip Scheinberg
1
,
A John Barrett
1
,
Ronan Desmond
1
,
Neal S Young
1
,
Christopher S Hourigan
1
Affiliation
1
Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
PMID:
30936058
PMCID:
PMC6457214
DOI:
10.1182/bloodadvances.2018030411
No abstract available
Publication types
Letter
Research Support, N.I.H., Intramural
Grants and funding
ZIA HL006163/ImNIH/Intramural NIH HHS/United States